FATE Operating Cash Flow (Statement)
Fate Therapeutics Inc · Operating Cash Flow (Statement)
FATE Operating Cash Flow (Statement)
Latest reported-$101.94Mperiod ending
FATE TTM Cash from Operations (-$15.37M → -$101.94M)
TTM operating cash flow (statement)
High-resolution chart · PNG
FATE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -101,944,000 | |
| -103,097,000 | |
| -106,084,000 | |
| -110,569,000 | |
| -115,614,000 | |
| -123,333,000 | |
| -122,874,000 | |
| -131,712,000 | |
| -140,566,000 | |
| -136,753,000 | |
| -132,263,000 | |
| -171,015,000 | |
| -187,789,000 | |
| -212,455,000 | |
| -248,208,000 | |
| -243,112,000 | |
| -221,440,000 | |
| -200,387,000 | |
| -162,870,000 | |
| -113,241,000 | |
| -110,599,000 | |
| -39,652,000 | |
| -39,229,000 | |
| -44,100,000 | |
| -33,205,000 | |
| -92,355,000 | |
| -83,175,000 | |
| -68,660,000 | |
| -52,378,000 | |
| -43,592,000 | |
| -38,650,000 | |
| -38,351,000 | |
| -44,652,000 | |
| -42,001,000 | |
| -36,905,000 | |
| -33,735,000 | |
| -31,394,000 | |
| -30,026,000 | |
| -29,823,000 | |
| -29,242,000 | |
| -28,857,000 | |
| -19,274,000 | |
| -18,397,000 | |
| -17,581,000 | |
| -15,971,000 | |
| -23,539,000 | |
| -22,419,000 | |
| -20,843,000 | |
| -18,794,000 | |
| -16,695,000 | |
| -15,373,000 | |
| -14,189,000 | |
| -13,485,000 |